The Levothyroxine Sodium Tablets, cataloged under National Stock Number 6505-01-212-7718, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Baxter Healthcare Corp IV Systems/gov Sales. Government technical data includes 6 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 3 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-212-7718 |
| Primary Part Number | NDC00048-1090-05 |
| Item Name | Levothyroxine Sodium Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Baxter Healthcare Corp IV Systems/gov Sales |
| Status | ACTIVE |
| Total Primary Container Quantity | 4 |
| Primary Container Content Quantity | 1000.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Active Medicament Medicinal Strength | 0.150 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT |
| Administration | ORAL |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| SYNTHROID | Baxter Healthcare Corp IV Systems/gov Sales (USA) |
| NDC00048-1090-05 PRIMARY | Baxter Healthcare Corp IV Systems/gov Sales (USA) |
| 3P1095 PRIMARY | Baxter Healthcare Corp IV Systems/gov Sales (USA) |
NSN 6505-01-212-7718 is a Levothyroxine Sodium Tablets, manufactured by Baxter Healthcare Corp IV Systems/gov Sales, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-212-7718 has 3 cross-referenced part numbers: SYNTHROID (Baxter Healthcare Corp IV Systems/gov Sales), NDC00048-1090-05 (Baxter Healthcare Corp IV Systems/gov Sales), 3P1095 (Baxter Healthcare Corp IV Systems/gov Sales).
There are 12 known substitutes for 6505-01-212-7718: 6505-00-915-1630, 6505-00-990-2021, 6505-01-042-9260 and 9 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00048-1090-05: Total Primary Container Quantity: 4; Primary Container Content Quantity: 1000.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Active Medicament Medicinal Strength: 0.150 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT. 7 total characteristics are documented in the Federal Logistics Information System.